New York Markets After Hours

Synnex shares decline as outlook edges earnings

SAN FRANCISCO (MarketWatch) — Synnex Corp. shares declined in the extended session Wednesday after the business process service provider’s beat of Wall Street quarterly expectations was overshadowed by its outlook.

Synnex
SNX, -1.10%
shares declined 1.8% to $72.60 on moderate volume after the company said it expects adjusted third-quarter earnings of $1.45 to $1.50 a share on revenue of $3.3 billion to $3.4 billion. Analysts forecast $1.53 a share on revenue of $3.29 billion.

The company also reported adjusted second-quarter earnings of $1.52 on revenue of $3.45 billion. Analysts surveyed by FactSet estimated $1.37 a share on revenue of $3.17 billion.

Bind Therapeutics Inc.
BIND, +0.92%
shares fell 16% to $10.84 on light volume after the nanomedicine company said it completed its research collaboration with Amgen Inc.
AMGN, -2.71%
and will not be pursuing development of a solid tumor treatment with the biotech giant.

Shares of Genesee & Wyoming Inc.
GWR, -0.77%
rose 4.8% to $109.56 on light volume after several board members purchased hundreds of shares, according to Securities and Exchange Commission filings late Wednesday.

Intraday Data provided by SIX Financial Information and subject to terms of use.
Historical and current end-of-day data provided by SIX Financial Information. Intraday data
delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Dow Jones & Company, Inc.
All quotes are in local exchange time. Real time last sale data provided by NASDAQ. More
information on NASDAQ traded symbols and their current financial status. Intraday
data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. S&P/Dow Jones Indices (SM)
from Dow Jones & Company, Inc. SEHK intraday data is provided by SIX Financial Information and is
at least 60-minutes delayed. All quotes are in local exchange time.